FDA: montelukast tablet bottles recalled

FDA: montelukast tablet bottles recalled

(HealthDay)—Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.

Bottles labeled as containing 30 tablets of 10-milligram montelukast sodium tablets instead contain 90 tablets of losartan potassium tablets.

There is a safety risk because taking losartan when not prescribed can cause , elevated potassium levels, and . The risk can be especially high for pregnant woman because losartan could harm or kill the fetus, the FDA said Friday.

The recalled bottles have the following lot numbers: MON17384, expiration date: 12/31/2019, and NDC: 31722-726-30. Patients who have the recalled bottles should contact their or pharmacist immediately, the FDA said.


Explore further

Label mix-up spurs recall of accord blood pressure meds

More information: More Information

Copyright © 2018 HealthDay. All rights reserved.

Citation: FDA: montelukast tablet bottles recalled (2018, September 5) retrieved 26 November 2020 from https://medicalxpress.com/news/2018-09-fda-montelukast-tablet-bottles-recalled.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
851 shares

Feedback to editors

User comments